Immune evasion of the CD1d/NKT cell axis

被引：14

作者：

Brutkiewicz, Randy R. ^{[1
]}

Yunes-Medina, Laura ^{[1
]}

Liu, Jianyun ^{[1
]}

机构：

[1] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 2018年 / 52卷

基金：

美国国家卫生研究院;

关键词：

KILLER T-CELLS; CD1D-MEDIATED ANTIGEN PRESENTATION; IMMUNODEFICIENCY-VIRUS-INFECTION; NKT CELLS; DENDRITIC CELLS; MURINE CYTOMEGALOVIRUS; LISTERIA-MONOCYTOGENES; ADAPTIVE IMMUNITY; MULTIPLE-MYELOMA; CYTOPLASMIC TAIL;

D O I：

10.1016/j.coi.2018.04.021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Many reviews on the CD1d/NKT cell axis focus on the ability of CD1d-restricted NKT cells to serve as effector cells in a variety of disorders, be they infectious diseases, cancer or autoimmunity. In contrast, here, we discuss the ways that viruses, bacteria and tumor cells can evade the CD1d/NKT cell axis. As a result, these disease states have a better chance to establish a foothold and potentially cause problems for the subsequent adaptive immune response, as the host tries to rid itself of infections or tumors.

引用

页码：87 / 92

页数：6

共 50 条

[21] Medullublastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
Liu, Daofeng
Song, Liping
Brawley, Vita
Robison, Nathan
Wei, Jie
Gao, Xiuhua
Ahmed, Nabil
Asgharzadeh, Shahab
Metelitsa, Leonid
JOURNAL OF IMMUNOLOGY, 2013, 190
[22] Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
Liu, Daofeng
Song, Liping
Brawley, Vita S.
Robison, Nathan
Wei, Jie
Gao, Xiuhua
Tian, Gengwen
Margol, Ashley
Ahmed, Nabil
Asgharzadeh, Shahab
Metelitsa, Leonid S.
CLINICAL IMMUNOLOGY, 2013, 149 (01) : 55 - 64
[23] Medullublastoma Expresses CD1d and Can Be Targeted for Immunotherapy with NKT Cells
Song, L.
Liu, D.
Metelitsa, L.
MODERN PATHOLOGY, 2013, 26 : 446A - 447A
[24] Medullublastoma Expresses CD1d and Can Be Targeted for Immunotherapy with NKT Cells
Song, L.
Liu, D.
Metelitsa, L.
LABORATORY INVESTIGATION, 2013, 93 : 446A - 447A
[25] Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway
Procópio, DO
Almeida, IC
Torrecilhas, ACT
Cardoso, JE
Teyton, L
Travassos, LR
Bendelac, A
Gazzinelli, RT
JOURNAL OF IMMUNOLOGY, 2002, 169 (07): : 3926 - 3933
[26] A cell-type specific CD1d expression program modulates invariant NKT cell development and function
Zimmer, MI
Colmone, A
Felio, K
Xu, HL
Ma, A
Wang, CR
JOURNAL OF IMMUNOLOGY, 2006, 176 (03): : 1421 - 1430
[27] Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis
Segawa, Seir
Goto, Daisuke
Yoshiga, Yohei
Hayashi, Taichi
Matsumoto, Isao
Ito, Satoshi
Sumida, Takayuki
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (04) : 481 - 486
[28] Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production
Lang, Gillian A.
Devera, T. Scott
Lang, Mark L.
BLOOD, 2008, 111 (04) : 2158 - 2162
[29] The length of lipids bound to human CD1d molecules modulates the affinity threshold of NKT cell activation
McCarthy, Corinna
Shepherd, Dawn
Fleire, Sebastian
Stronge, Victoria S.
Koch, Michael
Illarionov, Petr A.
Bossi, Giovanna
Salio, Mariolina
Denkberg, Galit
Reddington, Faye
Tarlton, Andrea
Reddy, B. Gopal
Schmidt, Richard R.
Reiter, Yoram
Griffi, Gillian M.
van der Merwe, P. Anton
Besra, Gurdyal S.
Jones, E. Yvonne
Batista, Facundo D.
Cerundolo, Vincenzo
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05): : 1131 - 1144
[30] Intrahepatic NKT cell and soluble CD1d have a significant role in the immuno pathogenesis of AIH but not in PBC
Takahashi, Hiroki
Oikawa, Tsunekazu
Amano, Katsushi
Tamaki, Shigeo
Kuniyasu, Yushi
Hokari, Atsushi
Ishikawa, Tomohisa
Zeniya, Mikio
HEPATOLOGY, 2006, 44 (04) : 227A - 228A

← 1 2 3 4 5 →